Trump drug price plan could nix investment, warns Roche / Photo: SEBASTIEN BOZON - AFP
-
Ledecky beats McIntosh to win 800m freestyle thriller
-
Fearless Wallabies stun weary Lions to win third Test 22-12
-
Double champion Walsh calls Phelps criticism 'frustrating'
-
Jaiswal and Deep keep India in the hunt against England
-
Piastri edges Norris as McLaren dominate Hungarian GP final practice
-
US envoy meets Israeli hostage families in Tel Aviv
-
McKeown beats Smith again for world backstroke double
-
New dad McEvoy adds 'unreal' world swimming gold to Olympic title
-
Walsh completes world butterfly double in riposte to Phelps
-
Turkey starts supplying Azerbaijani gas to boost Syria's power output
-
Thousands of young Catholics converge for grand Pope Leo vigil
-
SpaceX Crew Dragon docks with International Space Station
-
New push to reach plastic pollution pact
-
US do talking in pool after Phelps, Lochte slam worlds performance
-
Up to a million young Catholics expected for grand Pope Leo vigil
-
New push to reach plastic polution pact
-
Second seed Fritz ends Canadian hopes at ATP Toronto Masters
-
Japan sweats through hottest July on record
-
Jefferson-Wooden, Bednarek blaze to 100m titles at US trials
-
Son Heung-min to leave Tottenham this summer after decade
-
Richardson 'domestic violence' drama overshadows US trials
-
Bid to relocate US Space Shuttle Discovery faces museum pushback
-
Academics warn Columbia University deal sets dangerous precedent
-
Sevastova topples Pegula to book date with Osaka, Swiatek advances in Montreal
-
Former Olympic champion Mu-Nikolayev fails in worlds bid
-
Sensible and steely: how Mexico's Sheinbaum has dealt with Trump
-
Young leads at weather-hit PGA Wyndham Championship
-
US sprint star Richardson out of trials following arrest
-
Rublev, Tiafoe sweat out three-set wins in Toronto
-
Ex-porn actor to be Colombian equality minister
-
Olympic swim greats Phelps, Lochte, rip US World Championships performance
-
Brazilians burn Trump effigies as tariffs spark anger
-
Global stocks fall sharply on weak US job data, Trump tariffs
-
Lyles, Richardson scratch from 100m at US trials
-
NFL Commanders win key vote in quest for new stadium
-
US Fed governor to resign early at critical time for central bank
-
US keeper Turner joins Lyon from Notts Forest, loaned to MLS
-
Epstein accomplice Maxwell moved to minimum security Texas prison
-
Sevastova shocks fourth-ranked Pegula to book date with Osaka
-
End of the chain gang? NFL adopts virtual measurement system
-
Deep lucky to escape Duckett 'elbow' as India get under England's skin
-
Search intensifies for five trapped in giant Chile copper mine
-
Trump orders firing of US official as cracks emerge in jobs market
-
Trump deploys nuclear submarines in row with Russia
-
Colombian ex-president Uribe sentenced to 12 years house arrest
-
Wave of fake credentials sparks political fallout in Spain
-
Osaka ousts Ostapenko to reach WTA fourth round at Canada
-
Rovanpera emerges from home forests leading Rally of Finland
-
Exxon, Chevron turn page on legal fight as profits slip
-
Prosecutors call for PSG's Achraf Hakimi to face rape trial
NYSE - LSE
| CMSC | 0.09% | 22.87 | $ | |
| SCU | 0% | 12.72 | $ | |
| NGG | 1.99% | 71.82 | $ | |
| RIO | -0.2% | 59.65 | $ | |
| RBGPF | 0% | 74.94 | $ | |
| SCS | -1.47% | 10.18 | $ | |
| GSK | 1.09% | 37.56 | $ | |
| CMSD | 0.34% | 23.35 | $ | |
| BCC | -0.55% | 83.35 | $ | |
| RYCEF | 0.07% | 14.19 | $ | |
| BTI | 1.23% | 54.35 | $ | |
| VOD | 1.37% | 10.96 | $ | |
| RELX | -0.58% | 51.59 | $ | |
| JRI | -0.23% | 13.1 | $ | |
| AZN | 1.16% | 73.95 | $ | |
| BCE | 1.02% | 23.57 | $ | |
| BP | -1.26% | 31.75 | $ |
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
I.Matar--SF-PST
